KRAS and familial pancreatic carcinoma: In a study using exosomes to deliver small interfering RNAs (siRNAs) targeting KRAS in pancreatic cancer, researchers found that the exosomes penetrated deeply into the tumor core, significantly suppressing tumor growth (Kamerkar et al., 2017).